African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5182

Full Length Research Paper

Extended spectrum-β-lactamase producing Escherichia coli and Klebsiella pneumoniae causing urinary tract infection

Alia Batool
  • Alia Batool
  • Department of Allied Health Sciences, Fatima Memorial Hospital, College of Medicine and Dentistry, Lahore Pakistan.
  • Google Scholar
Hania Baig
  • Hania Baig
  • Department of Allied Health Sciences, Fatima Memorial Hospital, College of Medicine and Dentistry, Lahore Pakistan.
  • Google Scholar
Muhammad Usman Qamar
  • Muhammad Usman Qamar
  • Department of Microbiology, Faculty of Science and Technology, Government College University Faisalabad, Pakistan.
  • Google Scholar


  •  Received: 21 December 2015
  •  Accepted: 17 March 2016
  •  Published: 14 November 2016

Abstract

Extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae causing urinary tract infection (UTI) constitutes a significant therapeutic challenge.  The aim of this study was to investigate the frequency of ESBL producing Escherichia coli and Klebsiella pneumoniae isolated from urine samples. Clinical isolates of multidrug resistant Gram negative rods (n=102) were taken from urine specimens from tertiary care hospital Lahore. Micro-organisms were identified on the basis of their morphology, cultural characteristics, and confirmed using API 20E. Identified E. coli and K. pneumoniae were subjected to susceptibility testing using Kirby-Bauer disc diffusion method as per CLSI guidelines. Furthermore, phenotypic confirmation of ESBL production was done according to CLSI guidelines. Out of 102 multidrug resistant Gram negative rods 97 (95%) were ESBL producers isolated from different urine specimens from different wards of hospitals (emergency, ICU, urology ward); among these 64 (66%) were E. coli and 33 (34%) were K. pneumoniae.  Antimicrobial susceptibility pattern of ESBL producing pathogens showed that 75% of these pathogens were resistant to ciprofloxacin whereas most effective drug was meropenem and pipracillin+tazobactam.  Meropenem could be used as an alternative treatment option for UTI related to ESBL producing E. coli and K. pneumoniae. High prevalence of these ESBL producing pathogens are alarming and need special consideration.

 

Key words: Extended spectrum β-lactamases, urinary tract infection, Escherichia coli, Klebsiella pneumoniae.